Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5645277 | Annals of Allergy, Asthma & Immunology | 2016 | 6 Pages |
Abstract
Slow desensitization is a helpful procedure in treating patients with imatinib-induced nonimmediate reactions other than simple maculopapular exanthema. The reduced percentages of imatinib-induced CD4+CD25+CD134+ T cells in these patients may be associated with immune tolerance.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Jettanong MD, Pattarawat MSc, Pimpayao PhD, Supranee PhD, Pungjai RN,